The market is segmented based on Segmentation, By Product and Service (Test Kits and Testing Services), Technique (Amplicon-Based Approach and Hybridization-Based Approach), Design (Predesigned Gene Panels and Customized Gene Panels), Application (Cancer Risk Assessment, Diagnosis, and Pharmacogenetics), End-User (Hospitals and Clinics and Research Organizations and Academic Institutes) – Industry Trends and Forecast to 2032
.
The Global Gene Panel Market size was valued at USD 2.66 USD Billion in 2024.
The Global Gene Panel Market is projected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2032.
The major players operating in the market include BGI, IlluminaInc. AGilent TechnologiesInc, Eurofins Scientific, QIAGEN, OriGene TechnologiesInc., Bioneer Corporation, GenScript, Eurogentec, Twist Bioscience., BioCat GmbH, Thermo Fisher Scientific Inc, Novogene Co.Ltd, GENEWIZInc., Integrated DNA TechnologiesInc, F. Hoffmann-La Roche Ltd, ArcherDXInc. and GATC Biotech AG.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.